MY197096A - Treatment of b-cell malignancies by a combination jak and p13k inhibitor - Google Patents
Treatment of b-cell malignancies by a combination jak and p13k inhibitorInfo
- Publication number
- MY197096A MY197096A MYPI2020004284A MYPI2020004284A MY197096A MY 197096 A MY197096 A MY 197096A MY PI2020004284 A MYPI2020004284 A MY PI2020004284A MY PI2020004284 A MYPI2020004284 A MY PI2020004284A MY 197096 A MY197096 A MY 197096A
- Authority
- MY
- Malaysia
- Prior art keywords
- inhibitor
- treatment
- cell malignancies
- combination
- jak
- Prior art date
Links
- 239000003112 inhibitor Substances 0.000 title abstract 3
- 206010028980 Neoplasm Diseases 0.000 title abstract 2
- 230000036210 malignancy Effects 0.000 title abstract 2
- 102000010400 1-phosphatidylinositol-3-kinase activity proteins Human genes 0.000 abstract 1
- 101000997835 Homo sapiens Tyrosine-protein kinase JAK1 Proteins 0.000 abstract 1
- 101000997832 Homo sapiens Tyrosine-protein kinase JAK2 Proteins 0.000 abstract 1
- 108091007960 PI3Ks Proteins 0.000 abstract 1
- 102100033438 Tyrosine-protein kinase JAK1 Human genes 0.000 abstract 1
- 102100033444 Tyrosine-protein kinase JAK2 Human genes 0.000 abstract 1
- 210000003719 b-lymphocyte Anatomy 0.000 abstract 1
Landscapes
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
This invention relates to methods of treating B-cell malignancies using a combination of inhibitors of JAK1 and/or JAK2 and inhibitors of PI3K?.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2020004284A MY197096A (en) | 2016-10-07 | 2016-10-07 | Treatment of b-cell malignancies by a combination jak and p13k inhibitor |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| MYPI2020004284A MY197096A (en) | 2016-10-07 | 2016-10-07 | Treatment of b-cell malignancies by a combination jak and p13k inhibitor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MY197096A true MY197096A (en) | 2023-05-24 |
Family
ID=87738274
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MYPI2020004284A MY197096A (en) | 2016-10-07 | 2016-10-07 | Treatment of b-cell malignancies by a combination jak and p13k inhibitor |
Country Status (1)
| Country | Link |
|---|---|
| MY (1) | MY197096A (en) |
-
2016
- 2016-10-07 MY MYPI2020004284A patent/MY197096A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PH12016501987A1 (en) | Treatment of b-cell malignancies by a combination jak and p13k inhibitor | |
| PH12021552497A1 (en) | Enzyme inhibitors | |
| MY205416A (en) | Tyk2 inhibitors and uses thereof | |
| PH12016502099A1 (en) | 5-chloro-2-difluoromethoxyphenyl pyrazolopyrimidine compounds which are jak inhibitors | |
| MX2018005600A (en) | Pharmaceutical compositions and methods for indoleamine 2,3-dioxygenase inhibition and indications therefor. | |
| MX2017001656A (en) | Bruton's tyrosine kinase inhibitor combinations and uses thereof. | |
| EP4327809A3 (en) | Tyk2 inhibitors and uses thereof | |
| MY176853A (en) | N-((het)arylmethyl)-heteroaryl-carboxamides compounds as plasma kallikrein inhibitors | |
| MX2016001864A (en) | Inhibitors of plasma kallikrein. | |
| PH12019502049A1 (en) | Pyrimidopyrimidinones useful as wee-1 kinase inhibitors | |
| EA201792227A1 (en) | TREATMENT OF LUNG CANCER WITH GLUTAMINASE INHIBITORS | |
| EA201692332A1 (en) | Bordeaux Proteas Inhibitors for Use After Primary Anti-Cancer Therapy | |
| MX2017009632A (en) | Combination therapy using a cd19-adc and vincristine. | |
| MX2015014036A (en) | Inhibitors of metastasis. | |
| PH12019500368A1 (en) | Inhibitors of cellular metabolic processes |